Shenzhen S.E.
06:00:00 2024-04-29 pm EDT
5-day change
1st Jan Change
10
CNY
+1.32%
+9.53%
-2.06%
Edan Instruments, Inc. Approves Distribution for 2021
April 21, 2022 at 03:32 pm EDT
Edan Instruments, Inc. at its Annual General Meeting of 2021 on 20 April 2022, approved the Cash dividend/10 shares (tax included) of CNY 2.07000000.
Edan Instruments, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Apr. 25
CI
Edan Instruments, Inc. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on May 6, 2024
Mar. 28
CI
Edan Instruments, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Mar. 28
CI
Edan Instruments, Inc. Focus on Medical Technology Advancement Shines At Medica 2023
Nov. 14
CI
Edan Instruments, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
23-10-24
CI
Edan Instruments, Inc. Strengthens its APAC Business Landscape with Thailand Office Launch
23-08-31
CI
Edan Instruments, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
23-08-22
CI
Edan Instruments, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-04-26
CI
Edan Instruments, Inc. Announces Final Cash Dividend for the Year 2022, Payable on 28 April 2023
23-04-21
CI
Edan Instruments, Inc. Approves Cash Dividend for the Year 2022
23-04-20
CI
Edan Instruments, Inc. Proposes Final Cash Dividend for the Year 2022
23-03-28
CI
Edan Instruments, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-28
CI
Edan Instruments, Inc. Establishes Peru Office, Edan Diagnostics Peru S.A.C. in Lima
23-03-13
CI
Edan Instruments, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022
22-10-25
CI
Edan Instruments, Inc. Showcases Its First Molecular Diagnostics Analysis System, ClariLight CL30, at Medlab Asia & Asia Health 2022
22-10-19
CI
Edan Instruments, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
22-08-23
CI
Edan Instruments, Inc. Launches i20
22-07-26
CI
Edan Instruments, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-04-26
CI
Edan Instruments, Inc. Announces Cash Dividend for the Year 2021, Payable on 29 April 2022
22-04-22
CI
Edan Instruments, Inc. Approves Distribution for 2021
22-04-21
CI
Edan Instruments, Inc. Announces Appointment of Zheng Quanlu as Independent Director and Zhou Yirong as Non-Employee Supervisors
22-04-21
CI
Edan Instruments Slashes Final Dividend on Lackluster 2021 Earnings
22-03-25
MT
Edan Instruments, Inc. Announces Profit Distribution Proposal for the Year 2021
22-03-24
CI
Edan Instruments, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
22-03-23
CI
Tranche Update on Edan Instruments, Inc.'s Equity Buyback Plan announced on February 9, 2021.
22-02-08
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Edan Instruments, Inc. is a China-based company principally engaged in the research, development, manufacture, sales of medical electronic equipment products and in-vitro diagnostic products, as well as the provision of related services. The Company provides maternity product series, including doppler fetal heart beat monitors, ultrasonic doppler fetal heart beat monitors, fetal/maternal monitors and maternity integrated diagnostic monitoring systems; electrocardiograph series, including digital twelve-channel electrocardiographs, digital six-channel electrocardiographs, electrocardiographic workstations, single-channel electrocardiographs and multi-channel electrocardiographs; monitoring product series, including portable multi-variable monitors, central monitoring systems and oximeters, as well as ultrasonic image product series, including digital ultrasonic diagnostic systems and others. The Company is also involved in the spare parts sale and in vitro diagnostics products business.
More about the company
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
EDAN INSTRUMENTS, INC. 
